Antagonistic action of IFN-β and IFN-γ on high affinity Fcγ receptor expression in healthy controls and multiple sclerosis patients

Journal of Immunology

Volumn 161, Issue 3, 1998, Pages 1568-1574

  Van Weyenbergh, Johan ^a,d   Lipinski, Pawel ^a   Abadie, Annie ^a   Chabas, Dorothée ^b   Blank, Ulrich ^c   Liblau, Roland ^b   Wietzerbin, Juana ^a  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c INSTITUT PASTEUR   (France)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; RECOMBINANT BETA INTERFERON; RECOMBINANT GAMMA INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE ACTIVATION; MALE; MULTIPLE SCLEROSIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RESPIRATORY BURST;

ADULT; CELLS, CULTURED; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DOWN-REGULATION; FEMALE; HUMANS; INTERFERON TYPE II; INTERFERON-BETA; INTRACELLULAR FLUID; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MONOCYTES; MULTIPLE SCLEROSIS; RECEPTORS, IGG; RESPIRATORY BURST; RNA, MESSENGER; TIME FACTORS;

EID: 0032145474     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Panitch, H. S., R. L. Hirsch, A. S. Haley, and K. P. Johnson. 1987. Exacerbations of multiple sclerosis in patients treated with γ-IFN. Lancet i:893.
2. IFN-β Multiple Sclerosis Study Group. 1993. Interferon-β1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:656.
3. Paty, D., D. Li, UBC MS/MRI Study Group, and IFN-β Multiple Sclerosis Study Group. 1993. Interferon-βlb is effective in relapsing-remitting multiple sclerosis. II. MRI results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 43:662.
4. Jacobs, L. D., D. L. Cookfair, R. A. Rudick, R. M. Herndon, J. R. Richert, A. M. Salazar, J. S. Fischer, D. E. Goodkin, C. V. Granger, J. H. Simon, J. J. Alam, D. M. Bartoszak, D. N. Bourdette, J. Braiman, C. M. Braunscheidle, M. E. Coats, S. L. Cohan, D. S. Dougherty, R. P. Kinkel, M. K. Mass, F. E. Munschauer, R. L. Priore, P. M. Pullicino, B. J. Scherokman, B. Weinstock-Guttman, R. H. Whitham, and the Multiple Sclerosis Collaborative Research Group. 1996. Intramuscular IFN-β1a for disease progression in relapsing multiple sclerosis. Ann. Neurol. 39:285.
5. Ling, P. D., M. K. Warren, and S. N. Vogel. 1985. Antagonistic effect of IFN-β on the IFN-γ-induced expression of la antigen in murine macrophages, J. Immunol. 135:1857.
6. Ibana, K., M. Kitaura, T. Kato, Y. Watanabe, Y. Kawade, and S. Maramatsu. 1986. Contrasting effects of α/β- and γ-IFNs on expression of macrophage Ia antigens. J. Exp. Med. 163:1030.
7. Barna, B. P., S. M. Chou, B. Jacobs, B. Yen-Lieberman, and R. M. Ransohoff. 1989. Interferon-β impairs induction of HLA-DR antigen expression in cultured adult human astrocytes. J. Neuroimmunol. 23:45.
8. Weinstock-Guttrnan, B., R. Ransohoff, R. Kinkel, and R. Rudick. 1995. The IFNs: biological effects, mechanisms of action, and use in multiple sclerosis. Ann. Neural. 37:7.
9. Fabry, Z., C. S. Raine, and M. N. Hart. 1994. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol. Today 15:219.
10. Zhang, J., L. Howard, H. L. Weiner, and D. A. Hafler. 1992. Autoreactive T cells in multiple sclerosis. Int. Rev. Immunol. 9:183.
11. Hohfeld, R., M. Londei, L. Massacesi, and M. Salvetti. 1995. T-cell autoimmunity in multiple sclerosis. Immunol. Today 16:259.
12. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85:299.
13. - T lymphocytes. J. Immunol. 127:1420.
14. Zamvil, S. S., P. A. Nelson, D. J. Mitchell, R. L. Knobler, R. B. Fritz, and L. Steinman. 1985. Encephalitogenic T cell clones specific for myelin basic protein: an unusual bias in antigen recognition. J. Exp. Med. 162:21..
15. Genain, C. P., D. Lee Parritz, M. N. Nguyen, L. Massacesi, N. Joshi, R. Ferrante, K. Hoffman, M. Moseley, N. L. Letvin, and S. L. Hauser. 1994. In healthy primates, circulating autoreactive T cells mediate autoimmune disease. J. Clin. Invest. 94:1339.
16. Willenberg, D. O., and S. J. Prowse. 1983. Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis. J. Neuroimmunol. 5:99.
17. Genain, C. P., M. H. Nguyen, N. L. Letvin, R. Pearl, R. L. Davis, M. Adelman, M. B. Lees, C. Linington, and S. L. Hauser. 1995. Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J. Clin. Invest. 96:2966.
18. Panitch, H. S., C. J. Cooper, and K. P. Johnson. 1980. CSF antibody to myelin basic protein: measurement in patients with multiple sclerosis and subacute sclerosing panencephalitis. Arch. Neurol. 37:206.
19. Warren, K. G., I. Gatz, E. Johnson, and B. Mielke. 1994. Anti-myelin basic protein and anti-proteolipid protein specific forms in multiple sclerosis. Ann. Neurol. 35:280.
20. Merrill, J. E., D. A. Kono, J. Clayton, D. G. Ando, D. R. Hinton, and F. M. Hofman. 1992. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. USA 89:574.
21. Cuzner, M. L., G. M. Hayes, J. Newcombe, and M. N. Woodroofe. 1988. The nature of inflammatory components during demyelination in multiple sclerosis. J. Neuroimmunol. 20:203.
22. Goldenberg, P. Z., E. E. Kwon, J. A. Benjamins, J. N. Whitaker, R. H. Quarles, and J. W. Prineas. 1989. Opsonization of normal myelin by anti-myelin antibodies and normal serum. J. Neuroimmunol. 23:157.
23. Mosley, K., and M. L. Cuzner. 1996. Receptor-mediated phagocytosis of myelin by macrophages and microglia: effect of opsonization and receptor blocking agents. Neurochem. Res. 21:481.
24. Ulvestad, E., K. Williams, C. Vedeler, J. Antel, H. Nyland, S. Mork, and R. Matre. 1994. Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG. J. Neurol. Sci. 121:125.
25. Scolding, N. J., and D. A. S. Compston. 1991. Oligodendrocyte-macrophage interactions in vitro triggered by specific antibodies. Immunology 72:127.
26. van de Winkel, J. G. J., and P. J. A. Capel. 1993. Human IgG Fc receptors heterogeneity: molecular aspects and clinical implications. Immunol. Today 14: 215.
27. Ruuls, S. R., J. Bauer, K. Sontrop, I. Huitinga, B. A. 't Hart, and C. D. Dijkstra. 1995. Reative oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol. 56:207.
28. Raine, C. S. 1994. The Dale E. McFarlin memorial lecture: the immunology of the multiple sclerosis lesion. Ann. Neurol. 36:561.
29. Selmaj, K., C. S. Raine, B. Cannella, and C. F. Brosnan. 1991. Identification of lymphotoxin and TNF in multiple sclerosis lesions. J. Clin. Invest. 87:949.
30. Beck, J., P. Rondot, L. Catinot, E. Falcoff, H. Kirchner, and J. Wietzerbin. 1988. Increased production of IFN-γ and TNF precedes clinical manifestations in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol. Scand. 78: 318.
31. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415.
32. Ihle, J. N. 1996. STATs: signal transducers and activators of transcription. Cell 84:331.
33. Pearse, R. N., R. Feinman, K. Shuai, J. E. Darnell, Jr., and J. V. Ravetch. 1993. Interferon-γ-induced transcription of the high-affinity Fc receptor for IgG requires assembly of a complex that includes the 91-kDa subunit of transcription factor ISGF3. Proc. Natl. Acad. Sci. USA 90:4314.
34. Perez, C., J. Wietzerbin, and P. Benech. 1993. Two cis-DNA elements involved in myeloid-cell-specific expression and gamma IFN (IFN-γ) activation of the human high-affinity Fcγ receptor gene: a novel IFN regulatory mechanism. Mol. Cell. Biol. 13:2182.
35. Igarashi, K. I., M. David, A. Lamer, and D. S. Finbloom. 1993. In vitro activation of a transcription factor by gamma IFN requires a membrane-associated tyrosine kinase and is mimicked by vanadate. Mol. Cell. Biol. 13:3984.
36. Olesjak, E., and W. E. Stewart. 1985. Potentiation of the antiviral and anticellular activities of IFNs by mixtures of HuIFN-γ and HuIFN-α or HuIFN-β. J. Interferon Res. 5:361.
37. Vaiman, D., S. Pietrokovsky, B. Cohen, P. Benech, and J. Chebath. 1990. Synergism of type I and type II IFNs in stimulating the activity of the same DNA enhancer. FEES Lett. 265:12.
38. Lu, H., J. L. Riley, G. T. Babcock, M. Huston, G. R. Stark, J. M. Boss, and R. M. Ransohoff. 1995. Interferon (IFN) β acts downstream of IFN-γ-induced class II trans-activator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kDa DNA-binding protein, ISGF3-γ. J. Exp. Med. 182:1517.
39. Poser, C. M., D. W. Paty, L. Scheinberg, W. I. McDonald, F. A. Davis, G. C. Ebers, K. P. Johnson, W. A. Sibley, D. H. Silberberg, and W. W. Tourtelotte. 1983. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neural. 13:227.
40. 2 integrins. Exp. Cell Res. 222:209.
41. Chomczynski, P., and N. Sacchi. 1987. Single-step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162: 156.
42. Lipinski, P., and H. Retmanska. 1996. Horse spleen ferritin inhibits Superoxide production by equine blood monocytes in vitro. Free Radic. Biol. Med. 20:729.
43. Testa, U., L. Conti, N. M. Sposi, B. Varano, E. Tritarelli, W. Malorni, P. Samoggia, G. Rainaldi, C. Peschle, F. Belardelli, and S. Gessani. 1995. IFN-β selectively down-regulates transferrin receptor expression in human peripheral blood macrophages by a post-translational mechanism. J. Immunol. 155:427.
44. van Vugt, M. J., I. A. F. M. Heijnen, P. J. A. Capel, S. Y. Park, C. Ra, T. Saito, J. S. Verbeek, and J. G. J. van de Winkel. 1996. FcR γ-chain is essential for both surface expression and function of human FcγRI (CD64) in vivo. Blood 87:3593.
45. Petricoin, E., III, M. David, K. Igarashi, C. Benjamin, L. Ling, S. Goelz, D. S. Finbloom, and A. C. Lamer. 1996. Inhibition of alpha IFN but not gamma IFN signal transduction by phorbol esters is mediated by a tyrosine phosphatase. Mol. Cell. Biol. 16:1419.
46. Kotanides, H., and N. C. Reich. 1993. Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. Science 262:1265.
47. Lamer, A. C., M. David, G. M. Feldman, K. I. Igarashi, R. H. Hackett, D. S. A. Webb, S. M. Sweitzer, E. F. Petricoin, III, and D. S. Finbloom. 1993. Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science 262:1730.
48. Gosselin, E. J., K. Wardwell, D. R. Gosselin, N. Alter, J. L. Fisher, and P. M. Guyre. 1992. Enhanced antigen presentation using human Fcγ receptor (monocyte/macrophage)-specific immunogens. J. Immunol. 149:3477.
49. Heijnen, I. A. F. M., M. J. Van Vugt, N. A. Fanger, R. F. Graziano, T. P. M. de Wit, F. M. A. Hofhuis, P. M. Guyre, P. J. A. Capel, J. S. Verbeek, and J. G. J. van de Winkel. 1996. Antigen targeting to myeloid-specific human FcγRI/CD64 triggers enhanced antibody responses in transgenic mice. J. Clin. Invest. 97:331.
50. Dore-Duffy, P., C. Donovan and R. F. Todd, III. 1992. Expression of monocyte activation antigen Mo3 on the surface of peripheral blood monocytes from patients with multiple sclerosis. Neurology 42:1609.